GSK-580299
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK-580299, covering 2018-07-16 to 2018-07-16. Get the full timeline:
Most recent: Clinical Trial Update: The Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study [Phase 3]